TNNI3K Could be a Novel Molecular Target for the Treatment of Cardiac Diseases

E-ISSN： 2212-3962|4|3|203-210

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.4, Iss.3, 2009-11, pp. : 203-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases

By Poller W.

Zeitschrift für Kardiologie, Vol. 93, Iss. 3, 2004-03 ,pp. : 171-193

Springer Publishing Company

Access to resources Recommend Favorite

From molecular mechanisms of cardiac development to genetic substrate of congenital heart diseases

By Cecchetto Antonella Rampazzo Alessandra Angelini Annalisa Bianco Lucia Dal Padalino Massimo Stellin Giovanni Daliento Luciano

Future Cardiology, Vol. 6, Iss. 3, 2010-05 ,pp. : 373-393

Future Medicine

Access to resources Recommend Favorite

Emerging Novel Treatment Strategies for Diabetic Eye Diseases

Current Diabetes Reviews, Vol. 6, Iss. 1, 2010-01 ,pp. : 35-41

Bentham Science Publishers

Access to resources Recommend Favorite

The Cell Cycle can be a New Target for the Treatment of Cardiac Hypertrophy?

By Nagai T. Takano H. Komuro I.

Journal of Molecular and Cellular Cardiology, Vol. 33, Iss. 10, 2001-10 ,pp. : 1769-1771

Academic Press

Access to resources Recommend Favorite

A Novel Role for STAT3 in Cardiac Remodeling

By Yamauchi-Takihara K. Kishimoto T.

Trends in Cardiovascular Medicine, Vol. 10, Iss. 7, 2000-10 ,pp. : 298-303

Elsevier

Access to resources Recommend Favorite